Multivalent ligands targeting VEGFR
Invention
The invention consists of novel compounds for angiogenesis-targeted therapy and imaging particularly for diseases such as cancer where increased angiogenesis is deleterious. The compounds target the VEGF receptor (VEGFR) with 100-fold improvement in binding affinity, higher specificity and tumor cell uptake and improved blood clearance. The...
Published: 5/18/2020
|
Inventor(s):
Keywords(s):
Category(s): Technology Classifications > Medical Imaging, Technology Classifications > Therapeutic
|